Drug: doxorubicin hydrochloride Quarter: 2016Q3
Total Records: 406 Number of Pages: 21
| DRUGNAME | PT | EventCount |
|---|---|---|
| DOXORUBICIN HYDROCHLORIDE. | Skin toxicity | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Soft tissue infection | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Status epilepticus | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Streptococcal infection | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Subarachnoid haemorrhage | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Supraventricular tachycardia | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Syncope | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Systemic candida | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Vascular access complication | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Weight increased | 2 |
| DOXORUBICIN HYDROCHLORIDE. | Wound complication | 2 |
| Doxorubicin Hydrochloride (Actavis Inc) | Ascites | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Bone marrow failure | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Breast cancer recurrent | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Decreased appetite | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Hepatic failure | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Hepatocellular injury | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Hypoaesthesia oral | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Malignant neoplasm progression | 1 |
| Doxorubicin Hydrochloride (Actavis Inc) | Mucosal inflammation | 1 |
Total Records: 406 Number of Pages: 21